Skip to main content
    B

    Bruker Corporation (BRKR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $56.54
    +0.94 (+1.69%)

    Market Cap: $8.47B

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(35/39)
    Avg Surprise
    +18.20%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.42
    Range$0.40 - $0.45
    12 analysts
    EPS RevisionsNo revisions (7d)
    0
    11
    30d
    EPS Estimate DriftChange to current
    90d ago$0.55-23.7%
    60d ago$0.55-23.8%
    30d ago$0.42+0.6%
    7d ago$0.420.0%
    Current$0.42
    Revenue Consensus
    $868M
    Range$865M - $871M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.09
    Range$1.07 - $1.10
    13 analysts
    Revenue Consensus
    $1.0B
    Range$1.0B - $1.1B
    12 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.09---
    Sep 26EST
    		-$0.42---
    Jun 26
    Reported Aug 4
    		$0.49$0.38+28.95%Beat+53.1%
    Mar 26
    Reported May 6
    		$0.31$0.23+34.78%Beat-34.0%
    Dec 25
    Reported Feb 12
    		$0.59$0.65-9.23%Miss-22.4%
    Sep 25
    Reported Nov 3
    		$0.45$0.32+40.63%Beat-25.0%
    Jun 25
    Reported Aug 4
    		$0.32$0.42-23.81%Miss-38.5%
    Mar 25
    Reported May 7
    		$0.47$0.44+6.82%Beat-11.3%
    Dec 24
    Reported Feb 13
    		$0.76$0.74+2.70%Beat+8.6%
    Sep 24
    Reported Nov 5
    		$0.60$0.60+0.00%Beat-18.9%
    Jun 24
    Reported Aug 6
    		$0.52$0.51+1.96%Beat+4.0%
    Mar 24
    Reported May 2
    		$0.53$0.46+15.22%Beat-17.2%
    Dec 23
    Reported Feb 13
    		$0.70$0.66+6.06%Beat-5.4%
    Sep 23
    Reported Nov 2
    		$0.74$0.63+17.46%Beat+12.1%
    Jun 23
    Reported Aug 3
    		$0.50$0.49+2.04%Beat+11.1%
    Mar 23
    Reported May 4
    		$0.64$0.55+16.36%Beat+30.6%
    Dec 22
    Reported Feb 9
    		$0.74$0.72+2.78%Beat+25.4%
    Sep 22
    Reported Nov 3
    		$0.66$0.56+17.86%Beat+4.8%
    Jun 22
    Reported Aug 3
    		$0.45$0.45+0.00%Beat+2.3%
    Mar 22
    Reported May 4
    		$0.49$0.42+16.67%Beat+11.4%
    Dec 21
    Reported Feb 11
    		$0.59$0.58+1.72%Beat+1.7%
    Sep 21
    Reported Nov 1
    		$0.63$0.44+43.18%Beat+50.0%
    Jun 21
    Reported Aug 2
    		$0.44$0.38+15.79%Beat+109.5%
    Mar 21
    Reported May 5
    		$0.44$0.33+33.33%Beat+214.3%
    Dec 20
    Reported Feb 16
    		$0.58$0.56+3.57%Beat+9.4%
    Sep 20
    Reported Nov 2
    		$0.42$0.31+35.48%Beat-2.3%
    Jun 20
    Reported Aug 3
    		$0.21$0.05+320.00%Beat-36.4%
    Mar 20
    Reported May 6
    		$0.14$0.22-36.36%Miss-50.0%
    Dec 19
    Reported Mar 27
    		$0.53$0.59-10.17%Miss-1.9%
    Sep 19
    Reported Oct 31
    		$0.43$0.38+13.16%Beat+16.2%
    Jun 19
    Reported Aug 1
    		$0.33$0.30+10.00%Beat+32.0%
    Mar 19
    Reported May 2
    		$0.28$0.24+16.67%Beat+16.7%
    Dec 18
    Reported Feb 11
    		$0.54$0.54+0.00%Beat+5.9%
    Sep 18
    Reported Nov 1
    		$0.37$0.30+23.33%Beat+27.6%
    Jun 18
    Reported Aug 2
    		$0.25$0.25+0.00%Beat+8.7%
    Mar 18
    Reported May 3
    		$0.24$0.23+4.35%Beat+26.3%
    Dec 17
    Reported Feb 8
    		$0.51$0.49+4.08%Beat+10.9%
    Sep 17
    Reported Nov 2
    		$0.29$0.26+11.54%Beat-
    Jun 17
    Reported Aug 3
    		$0.23$0.20+15.00%Beat-
    Mar 17
    Reported May 3
    		$0.19$0.19+0.00%Beat-
    Dec 16
    Reported Feb 13
    		$0.46$0.36+27.78%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.35%
    Forward Annual Dividend$0.20
    Payout Ratio16.00%
    FrequencyQuarterly
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR+0.00%
    5Y CAGR+4.56%
    BRKR dividend history and ex-dividend datesRun BRKR in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio30.73EV/EBITDA49.35x
    Price/FCF91.70xFCF Yield1.09%
    Profitability
    Profit Margin-2.04%Operating Margin9.88%
    ROE-3.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio1.85xQuick Ratio0.92x
    Trading Statistics
    Beta1.22Avg Volume2.37M
    52-Week High$66.9852-Week Low$32.27

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$58.87
    SMA 20$60.76
    SMA 50$58.59
    SMA 200$49.76
    EMA 10$58.21
    EMA 20$59.16
    EMA 50$58.78
    EMA 200$51.84

    MACD

    Line: -0.71Signal: 0.17Hist: -0.87

    ADX

    ADX: 19.2+DI: 16.0-DI: 23.3

    Aroon & PSAR

    Aroon Up56.0
    Aroon Down8.0
    PSAR$62.47

    Bollinger Bands

    Upper Band$66.85
    Lower Band$54.66
    %B Position2007%(Upper)
    Band Width0.15

    RSI (14-Day)

    Neutral
    42.6

    Momentum Oscillators

    Stoch %K12.1
    Stoch %D10.8
    Williams %R-83.3
    ROC (10d)-8.7%
    Momentum-5.40
    CCI (20d)-127.2
    MFI (14d)39.0

    Volatility Measures

    ATR (14d)$3.05(5.4%)
    StdDev (20d)3.05
    Hist Vol45.5%(High)

    Volume Flow

    VWAP$56.00
    OBV-11.1M
    AD Line-107.1M
    CMF (20d)-0.110

    Volume Metrics

    Avg Vol (20d)2.2M
    Vol Ratio0.9x
    VWMA (20d)$60.78

    Pivot Points

    R3$61.11
    R2$59.59
    R1$57.60
    Pivot Point$56.08
    S1$54.09
    S2$52.57
    S3$50.58

    Advanced Oscillators

    TSI-6.18
    Ultimate Osc47.5
    KST23.32

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$838.50M$823.40M$977.20M$860.50M$797.40M$801.40M$979.60M$864.40M$800.70M$721.70M$854.50M$742.80M
    Cost of Revenue$422.50M$443.60M$528.00M$481.10M$439.50M$410.20M$486.30M$445.60M$416.10M$368.90M$424.20M$360.00M
    Gross Profit$416.00M$379.80M$449.20M$379.40M$357.90M$391.20M$493.30M$418.80M$384.60M$352.80M$430.30M$382.80M
    Operating Expenses$481.30M$369.60M$372.90M$431.20M$346.00M$359.40M$421.20M$350.70M$336.50M$288.00M$326.80M$258.30M
    R&D$94.30M$101.30M$99.60M$98.30M$100.20M$97.10M$104.40M$98.10M$92.20M$81.80M$83.50M$71.30M
    SG&A$238.90M$242.10M$247.20M$242.50M$231.40M$225.40M$247.30M$229.90M$221.30M$195.30M$211.20M$177.60M
    Operating Income$-65,300,000$10.20M$76.30M$-51,800,000$11.90M$31.80M$72.10M$68.10M$48.10M$64.80M$103.50M$124.50M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$8.10M$20.00M$11.40M$6.70M$16.00M$12.80M$24.20M$0$0$5.30M
    Income Before Tax$-40,700,000$21.90M$68.20M$-71,800,000$500,000$25.10M$56.10M$55.30M$23.90M$71.60M$240.90M$119.20M
    Income Tax Expense$14.20M$2.50M$37.80M$-14,100,000$-3,100,000$8.70M$40.70M$14.80M$16.10M$19.80M$37.10M$30.80M
    Net Income$-50,900,000$15.70M$29.20M$-58,500,000$4.20M$16.80M$13.90M$40.30M$7.60M$52.00M$204.60M$88.70M
    EBITDA$17.30M$80.20M$126.30M$-16,100,000$56.60M$75.50M$109.00M$106.30M$69.10M$106.30M$278.20M$145.80M
    EBIT$-40,700,000$21.90M$68.20M$-71,800,000$500,000$25.10M$56.10M$55.30M$23.90M$71.60M$240.90M$119.20M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BRKR

    Government Contracts

    Gov Obligations (TTM)
    -$10156
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    -100.5%
    Active Awards
    2
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    BRKR Valuation and Fair Value

    P/E
    30.7x
    Forward P/E
    13.8x
    EV/EBITDA
    49.4x
    P/FCF
    91.7x
    PEG
    1.5x
    See GNG's fair value

    BRKR Profitability: Margins, ROIC and FCF

    Gross margin
    46.4%
    Operating margin
    9.9%
    Net margin
    -2.0%
    ROE
    -3.0%
    FCF margin
    2.7%
    FCF yield
    1.1%

    BRKR Competitors

    CompanyTicker
    Hinge Health, Inc.HNGE
    TG Therapeutics IncTGTX
    Caris Life Sciences, Inc. Common StockCAI
    Axsome Therapeutics IncAXSM
    Kymera Therapeutics IncKYMR
    Abivax SA American Depositary SharesABVX
    Cytokinetics IncCYTK
    AptarGroup IncATR

    Sector: Healthcare

    BRKR Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    2
    Buy
    5
    Hold
    5
    Sell
    1
    Strong Sell
    0

    BRKR Bull Case vs Bear Case

    Bear case

    • BRKR has a -2.0% net profit margin.

    BRKR Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    10.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.42
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 11 down

    BRKR Dividend

    Forward yield
    0.4%
    Payout ratio
    16.0%
    3Y DPS growth
    0.0%
    5Y DPS growth
    4.6%
    Pay months
    Jan, Apr, Jul, Oct
    BRKR dividend history

    Frequently Asked Questions About BRKR

    What is BRKR's current dividend yield?

    Bruker Corporation (BRKR) has a forward dividend yield of 0.35%.

    Does BRKR pay dividends?

    Yes, Bruker Corporation pays dividends with a forward dividend yield of 0.35%.

    What is BRKR's P/E ratio?

    Bruker Corporation has a price-to-earnings (P/E) ratio of 30.73.

    What is BRKR's market cap?

    Bruker Corporation (BRKR) has a market capitalization of $8.47B with a current stock price of $56.54.

    Related stocks

    Sector: Healthcare

    All stocks starting with B

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In